Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study

Pellanda A. F., De Bari B., Deniaud-Alexandre E., Krengli M., Van Houtte P., Richetti A., ...More

CHINESE JOURNAL OF CANCER RESEARCH, vol.29, no.6, pp.521-532, 2017 (SCI-Expanded) identifier identifier identifier


Objective: Primary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.